glp 1 decrease inflammation GLP-1 and Inflammation: How These Drugs Ease Arthritis GLP-1 therapy isn't just about

References Hutchinson J

Food Chem 368:130807 Zhong L, Carere J, Mats L, Lu Z, Lu F, Zhou T (2021) Formation of glutathione patulin conjugates associated with yeast fermentation contributes to patulin reduction

Sanofi Industry Developments July 2026: Novo Nordisk received CDSCO approval for Wegovy (semaglutide) as the first and only GLP-1 receptor agonist approved in India for noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver fibrosis, expanding the drug's indication beyond weight management and type 2 diabetes

[12] Limited observational data suggest that naltrexone does not significantly increase major congenital anomalies, yet its use for weight management in pregnancy is discouraged because long-term neurodevelopmental outcomes remain unclear